1. Home
  2. MSC vs PRAX Comparison

MSC vs PRAX Comparison

Compare MSC & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MSC

Studio City International Holdings Limited

HOLD

Current Price

$2.70

Market Cap

562.4M

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$303.31

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSC
PRAX
Founded
2000
2015
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
562.4M
9.6B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
MSC
PRAX
Price
$2.70
$303.31
Analyst Decision
Strong Buy
Analyst Count
0
15
Target Price
N/A
$572.13
AVG Volume (30 Days)
3.6K
320.9K
Earning Date
05-07-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$6,395.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.16
$26.70
52 Week High
$6.63
$354.87

Technical Indicators

Market Signals
Indicator
MSC
PRAX
Relative Strength Index (RSI) 44.21 47.79
Support Level N/A $289.02
Resistance Level $3.26 $322.32
Average True Range (ATR) 0.29 16.88
MACD -0.02 -0.27
Stochastic Oscillator 47.12 47.62

Price Performance

Historical Comparison
MSC
PRAX

About MSC Studio City International Holdings Limited

Studio City International Holdings Ltd is a gaming, retail, and entertainment resort located in Cotai, Macau. It operates Studio City Casino with around 250 mass-market gaming tables; including tables for VIP rolling chip operations, and 552 gaming machines. Studio City features luxury hotel rooms, diverse food and beverage establishments, and complementary retail space. In addition, the company offers non-gaming attractions, including the world's first figure-8 Ferris wheel, a deluxe nightclub and karaoke venue, a live performance arena, an outdoor and an indoor water park. Geographically, the company derives the majority of its revenue from the Macau region.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: